Article
Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: implications for genetic predisposition and immune regulation.
Cytokine - 1 Nov 1991
Jacob C O, Hwang F, Lewis G D, Stall A M
Abstract excerpt
Recombinant tumor necrosis factor alpha (TNF-alpha) administration significantly delayed the development of lupuslike nephritis in the New Zealand black x New Zealand white (NZB x NZW)F1 and to a lesser extent in the MRL-lpr/lpr model systems. TNF-alpha treatment was effective when treatment was...
Topics
- Animals
- Antibodies, Antinuclear
- Base Sequence
- Disease Models, Animal
- Genetic Predisposition to Disease
- Histocompatibility Antigens Class II
- Lupus Erythematosus, Systemic
- Lupus Nephritis
- Macrophages
- Mice
- Mice, Inbred NZB
- Mice, Mutant Strains
- Molecular Sequence Data
- Polymorphism, Restriction Fragment Length
- Recombinant Proteins
- Tumor Necrosis Factor-alpha
